Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Chinese authorities approve Sino Pharma’s lenalidomide for multiple melanoma

pharmaceutical-technologyJanuary 21, 2019

Tag: Sino Pharma , Lenalidomide , multiple melanoma , anti-tumour drug

PharmaSources Customer Service